SkyQuest projects that the global Precision Medicine Market will attain a value of USD 75.30 billion by 2031, with a CAGR of 11.4% during the forecast period (2024-2031). The precision medicine market will grow exponentially through rapid genomic research, biotechnology, and data analytics. With growing incidences of chronic diseases like cancer and cardiovascular conditions, there is an impending requirement for personalized treatment plans that precision medicine offers. The basis of precision medicine is, therefore, a unique concept where two individuals infected by the same disease do not necessarily have to respond to the sickness in the same way physically.

Download a detailed overview:
https://www.skyquestt.com/sample-request/precision-medicine-market

Browse in-depth TOC on "Precision Medicine Market"

·      Pages – 157

·      Tables - 91

·      Figures – 76

Precision Medicine Market Overview:

Hospitals & Clinics Dominate the Market Share by Offering Advanced and Improved Diagnostic Treatments

The hospitals and clinics segment forms the dominant end-user landscape within the precision medicine market, as hospitals are the very places that provide acute care to patients requiring advanced diagnostics and personalized treatments. Hospitals are better equipped and skilfully adept at adopting complex genome-based tests and molecular diagnostics. Substantial investments by healthcare systems and government initiatives in integrating precision medicine into standard clinical practices are also predicted to dominate the segment by improving patient outcomes and raising healthcare efficiency.

Home Care Settings to be the Fastest Growing as Individual Patient Care Becomes More Prevalent

Home care settings are one of the most rapidly growing areas in precision medicine. Technologies that mean tests can be conducted away from hospitals have been the driver of this growth, where care is then given to patients as an individual—something which has not been possible other than in hospitals. The drivers like portable diagnostic instruments and companion diagnostics, together with remote monitoring systems and telemedicine services are driving the growth of this market.

North America Dominates the Global Market Owing to the Rising Number of Cancer Patients

North American precision medicine market is expected to hold major market share in this forecasted period. Cancer being the leading cause of death in this region, have underscored the need for more enhanced treatment modalities such as precision medicine. The region has established key facilities for genomic studies and individualized treatment. The degree of awareness regarding precision medicine is very high, and the emphasis on the ever-increasing need to provide patients with individualized cancer treatments favours the growth of the market.

Precision Medicine Market Insights:

Drivers

·      Rising Incidence of Chronic and Genetic Diseases

·      Advancements in Genomic Technologies

·      Patient-Centric Approach and Preventive Medicine

Restraints

·      High Cost of Precision Medicine Technologies

·      Data Privacy and Security Concerns

·      Interpretation Difficulties and Clinical Relevance

Prominent Players in Precision Medicine Market

·      Illumina, Inc.

·      Thermo Fisher Scientific Inc.

·      Novartis AG

·      Abbott Laboratories

·      Agilent Technologies

·      Almac Group

·      Amgen Inc.

·      Astellas Pharma Inc.

·      AstraZeneca PLC

Key Questions Answered in Precision Medicine Market Report

·      What is Precision Medicine?

·      How big is the Precision Medicine Market?

·      At what value will the Precision Medicine Market grow during the forecasted period?

This report provides the following insights:

·      Analysis of key drivers (growing demand for better data security, rising adoption of Blockchain and IoT technologies, increasing use of decentralized systems in different industry verticals), restraints (interoperability issues with legacy systems, complexities in integration with existing infrastructure, concerns regarding scalability of gas cleaning technologies systems), and opportunities (growing demand for data monetization, rising demand for transparent yet trusted transactions), influencing the growth of precision medicine market.

·      Market Penetration: All-inclusive analysis of product portfolio of different market players and status of new product launches.

·      Product Development/Innovation: Elaborate assessment of R&D activities, new product development, and upcoming trends of the precision medicine market.

·      Market Development: Detailed analysis of potential regions where the market has potential to grow.

·      Market Diversification: Comprehensive assessment of new product launches, recent developments, and emerging regional markets.

·      Competitive Landscape: Detailed analysis of growth strategies, revenue analysis, and product innovation by new and established market players.

About Us:

SkyQuest is an IP focused Research and Investment Bank and Accelerator of Technology and assets. We provide access to technologies, markets and finance across sectors viz. Life Sciences, CleanTech, AgriTech, NanoTech and Information & Communication Technology.

We work closely with innovators, inventors, innovation seekers, entrepreneurs, companies and investors alike in leveraging external sources of R&D. Moreover, we help them in optimizing the economic potential of their intellectual assets. Our experiences with innovation management and commercialization have expanded our reach across North America, Europe, ASEAN and Asia Pacific.

Contact:

Mr. Jagraj Singh

Skyquest Technology

1 Apache Way,

Westford,

Massachusetts 01886

USA (+1) 351-333-4748

Email: [email protected]

Visit Our Website: https://www.skyquestt.com/